25 results for “parkinson”. Showing 25 of 39,449.
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
parkinsonism cohort, the Parkinson's Progression Markers Initiative (PPMI) international
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
Parkinson's disease individuals with normal cognition, 121 Parkinson's disease
Lipid pathway dysfunction is prevalent in patients with Parkinson's disease.
Parkinson's disease. Moreover, the hallmark Parkinson's disease pathological
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
Parkinson's, the Michael J Fox Foundation for Parkinson's Research
Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.
Parkinson's disease patients. Moreover, nigral idiopathic Parkinson's disease
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Parkinson's disease from healthy controls. We used the well
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
Parkinson's Genetics Program, the International Parkinson's Disease Genomics
Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
clusterin predicts and differentiates Parkinson's disease from atypical parkinsonism.
Parkinson's disease - genetic cause.
parkinsonism, but also rarely as typical Parkinson's disease. Majority
Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Parkinson's disease. Clinically, Parkinson's disease patients with GBA mutations
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Parkinson's disease have increased the scope of biological knowledge
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Parkinson's disease cases, 13 431 Parkinson's disease proxy
Gut-brain axis and environmental factors in Parkinson's disease: bidirectional link between disease onset and progression.
Parkinson's disease has long been considered a disorder that
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.
Parkinson's disease. Their application in Parkinson's disease diagnosis
Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.
Parkinson's disease, we performed a case-control study in two regions
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
Parkinson's disease. We examined whether a genetic burden of variants
Large-scale rare variant burden testing in Parkinson's disease.
Parkinson's disease has a large heritable component and genome
The pathogenesis of Parkinson's disease.
Parkinson's disease is a progressive neurodegenerative condition associated with
The gut-brain axis in early Parkinson's disease: from prodrome to prevention.
Parkinson's disease: from prodrome to prevention. Oliver PJ(1)(2), Civitelli
Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.
Parkinson's disease are an area of extensive research that
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
Parkinson's disease; however, individuals with Parkinson's disease are often
The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.
parkinsonism. Several different lines of research support this relationship. First
Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions.
parkinsonism, which has the same clinical presentation and neuropathology as Parkinson
Impaired dopamine release in Parkinson's disease.
Parkinson's disease is the second most common neurodegenerative disease
LRRK2 and Proteostasis in Parkinson's Disease.
Parkinson's disease is a neurodegenerative condition initially characterized by the presence